Human ADP-Ribosyl Cyclase 2 quantitates human ADP-Ribosyl Cyclase 2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ADP-Ribosyl Cyclase 2.
Human ADP-Ribosyl Cyclase 2 quantitates human ADP-Ribosyl Cyclase 2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ADP-Ribosyl Cyclase 2.
Human ADP-Ribosyl Cyclase 2 quantitates human ADP-Ribosyl Cyclase 2 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human ADP-Ribosyl Cyclase 2.
The antigen 1 of bone marrow stromal cells (BST1) is an anchored molecule of glycosylphosphatidylinositol derived from the stromal cell line that facilitates the growth of pre-B cells. BST1, also known as ADP ribose cyclase 2 and DAMP-1, is an enzyme expressed by the BST1 gene in humans. BST1 expression is improved in stromal bone marrow cell lines derived from rheumatoid arthritis patients. Polyclonal B cell abnormalities in rheumatoid arthritis can be attributed, at least in part, to the overexpression of BST1 in the stromal cell population.
Sensitivity
Sensitivity of the assay: 0.06 ng/mL.
Measurement range
Dose range: 0.06 to 12.50 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: CD157 (BST1).
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17114443
Specifications
Accession number
114/A10; A530073F09; ADP-ribosyl cyclase 2; ADP-ribosyl cyclase/ADP-ribose hydrolase 2 cyclic; Antigen BP3; stromal antigen 1 of bone marrow; stromal antigen 1 of bone marrow; Bp3; Bp-3; Alloantigen BP-3; BST1; BST-1; Bsta1; cADPR hydrolase 2; CD157; CD157 antigen;